ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 616348 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 616348; 2) Community: the network communities that were significantly associated with the response to NSC 616348; 3) Molecule: the relationships between components within communities and NSC 616348; 4) MDR: the compounds that were significantly associated with the NSC 616348.

NSC Compound Enrichment Correlation
NSC 676315 Null 0.0247898374452139 0.25782991
NSC 679198 Null 0.0247898374452139 0.43468011
NSC 680418 Null 0.0247898374452139 0.61612332
NSC 683404 Null 0.0247898374452139 0.24156053
NSC 683555 Camptothecin Derivative 0.0247898374452139 0.77911439
NSC 690266 ANTINEOPLASTIC-690266 0.0247898374452139 0.65340963
NSC 714680 Null 0.0247898374452139 0.21293316
NSC 717066 Null 0.0247898374452139 0.47613826
NSC 722900 N-(3-Iodo-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylened ioxy-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline 0.0247898374452139 0.65041053
NSC 724779 1-{[(1R,4S,5R,8S,12R,13R)-1,5-dimethyl-10-(trifluoromethyl)- 11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec-9- en-9-yl]methyl}-4-{[1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(tr ifluoromethyl)-1 0.0247898374452139 0.18127789
Total:98  Current:51    [First] [Prev] [Next] [Last]